C12N 2770/16061
Methods of inactivation or attenuation
C12N2770/16061 (Methods of inactivation or attenuation) appears on 11 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 20
- Assignees
- 8
- Inventors
- 26
- Latest grant
- 2 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 2 | 0 |
| 2008 | 1 | 2 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 3 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes2 Nov 2021US 11,160,849 B2Kewpie Corporation
- Feline calicivirus vaccine24 Sep 2019US 10,421,790 B2Intervet Inc.
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Antiviral agent24 Jan 2017US 9,549,949 B2Nbc Meshtec Inc.
- Methods for viral inactivation and other adventitious agents15 Nov 2016US 9,493,744 B2Genentech, Inc.
- Porcine sapovirus isolates and immunogenic compositions therefrom2 Jul 2026US 2026/0183379 A1Iowa State University Research Foundation, Inc.
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents25 May 2023US 2023/0159886 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents9 Jul 2020US 2020/0216799 A1Genentech, Inc.
Most cited
By later US patents
- Hemorrhagic feline calicivirus5US 7,449,323 B2The Regents of the University of California · 2008
- Inactivated vaccine against feline calicivirosis4US 6,534,066 B1Merial Limited · 2003
- Antiviral agent2US 9,549,949 B2Nbc Meshtec Inc. · 2017
- Inactivated vaccine against feline calicivirosis1US 7,029,682 B2Merial Limited · 2006
- Virulent systemic feline calicivirus1US 7,264,816 B2The Regents of the University of California · 2007